SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-018489
Filing Date
2020-08-14
Accepted
2020-08-14 16:31:51
Documents
42
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10013955_10q.htm 10-Q 326222
2 EXHIBIT 31.1 brhc10013955_ex31-1.htm EX-31.1 12052
3 EXHIBIT 31.2 brhc10013955_ex31-2.htm EX-31.2 12062
4 EXHIBIT 32.1 brhc10013955_ex32-1.htm EX-32.1 5098
5 EXHIBIT 32.2 brhc10013955_ex32-2.htm EX-32.2 5097
  Complete submission text file 0001140361-20-018489.txt   2468743

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aryb-20200630.xml EX-101.INS 239765
7 XBRL TAXONOMY EXTENSION SCHEMA aryb-20200630.xsd EX-101.SCH 32976
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aryb-20200630_cal.xml EX-101.CAL 21133
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aryb-20200630_def.xml EX-101.DEF 202757
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aryb-20200630_lab.xml EX-101.LAB 378215
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aryb-20200630_pre.xml EX-101.PRE 251143
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 2122842300
ARYA Sciences Acquisition Corp II (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 201105629
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences